The modulatory effect of NRF2 signaling on TGFβ1-EMT changes may provide a protective role against renal fibrogenesis, and further suggests the potential promise of small molecule NRF2 activators as a preventive intervention of CKD and fibrogenic diseases. Here, TGFB1 is linked to chronic kidney disease.